Bioavailability and toxicokinetic studies are essential in order to establi
sh dose-response relationships of widely distributed environmental toxicant
s such as benzo[a] pyrene (BaP), a polycyclic aromatic hydrocarbon. Fischer
344 rats were exposed for 4 h (via nose-only inhalation) to aerosol exposu
re concentrations of 0.1, 1.0, and 2.5 mg/m(3) of BaP absorbed onto carbon
black particles using a state-of-the-art model aerosol generation system. N
ominal and chamber concentrations of the particulate aerosol were determine
d gravimetrically with a seven-stage cascade impactor. The average aerosol
for the 3 exposure concentrations used in this study exhibited a trimodal d
istribution with 93% cumulative mass less than 15.85 mum, 89% cumulative ma
ss less than 10 mum, 55.3% cumulative mass less than 2.5 mum, and 38% less
than 1 mum. Fifty-five percent of the aerosol had a cumulative mass less th
an PM2.5 and the mass median aerodynamic diameter (MMAD) +/- geometric stan
dard deviation (GSD) for this mode was 1.7 +/- 0.085 mum. Plasma and lung s
amples were collected at 30, 60, 120, and 240 min postexposure. The concent
rations of BaP parent compound and metabolites were determined by highperfo
rmance liquid chromatography. The toxicokinetic parameters were computed fr
om the time course of plasma BaP concentration. The bioavailability of BaP
increased as a function of exposure concentration, and toxicokinetic analys
is indicates first-order pharmacokinetics for BaP. However, some toxicokine
tic parameters such as clearance and volume of distribution remained consta
nt throughout the duration of the postexposure period. BaP and its metaboli
te concentrations in plasma peaked at 1 h postexposure. At 240 min postexpo
sure, only trace levels of BaP remained in the plasma. The BaP metabolites
in the lung showed an identical trend where no parent compound was detected
. Among the metabolites detected, BaP 4, 5-, 7, 8-, and 9, 10-dihydrodiols,
3-OH-BaP, and 9-OH-BaP were predominant.